AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

DAPAGLIFLOZIN 5 Mg ; METFORMIN HYDROCHLORIDE 1000 Mg ;

10 registrations across 1 African market— 10 active

Markets with DAPAGLIFLOZIN 5 Mg ; METFORMIN HYDROCHLORIDE 1000 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Dapablix Met 5/1000 mg
Extended Release Film Coated Tablets
🇪🇬EgyptAL ESRAA PHARMACEUTICAL OPTIMA-EGYPTactive
Xigduo 5/1000 mg
Film Coated Tablets
🇪🇬EgyptAstraZeneca Egypt for Pharmaceutical Industriesactive
Diagliflomet
Extended Release Tablet
🇪🇬EgyptCareval for pharmaceutical industriesactive
Diglifloz Plus
Film Coated Tablets
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
Dapablix Met 5/1000 mg
Extended Release Film Coated Tablets
🇪🇬EgyptAL ESRAA PHARMACEUTICAL OPTIMA-EGYPTactive
Xigduo 5/1000 mg
Film Coated Tablets
🇪🇬EgyptAstraZeneca Egypt for Pharmaceutical Industriesactive
Dexiglofozin plus 5/1000 mg
Extended Release Film Coated Tablets
🇪🇬EgyptZeta Pharma for Pharmaceutical Industries (Zeta Pharma)active
Dexiglofozin plus 5/1000 mg
Extended Release Film Coated Tablets
🇪🇬EgyptZeta Pharma for Pharmaceutical Industries (Zeta Pharma)active
Diagliflomet
Extended Release Tablet
🇪🇬EgyptCareval for pharmaceutical industriesactive
Forminodab 5/1000mg
Extended release bilayer film coated tablets
🇪🇬EgyptHikma pharmaactive

DAPAGLIFLOZIN 5 Mg ; METFORMIN HYDROCHLORIDE 1000 Mg ; in Africa — Regulatory Overview

DAPAGLIFLOZIN 5 Mg ; METFORMIN HYDROCHLORIDE 1000 Mg ; is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.